Get the latest local stories in your inbox.
Science, Tech & Medicine in ...
BioMarin said the FDA accepted a supplemental filing to convert VOXZOGO from accelerated to full approval for children with achondroplasia; PDUFA date is Feb. 28, 2027.
Jul 15, 2026
San Rafael's BioMarin Snags Crucial FDA Shot At Full Voxzogo Approval
Mar 16, 2026
Bay Area’s Morning Internet Jolt Knocks Xfinity And Friends Offline
Dec 19, 2025
San Rafael’s BioMarin Drops $4.8 Billion Bet On Rare-Disease Rival
Brief internet outages hit the Bay Area on March 16, with Xfinity customers among those reporting dropouts and monitoring sites flagging wider spikes.
BioMarin will buy Amicus for roughly $4.8 billion, folding two marketed rare‑disease drugs into its portfolio as the companies eye a Q2 2026 close. The agreement is subject to shareholder and regulatory approvals.
Newsletter Signup
Enter your email, choose one or more newsletters, and we will only send updates for the metros you select.
* indicates required
Select at least one newsletter.
